Farolfi A, Hadaschik B, Hamdy FC, Herrmann K, Hofman MS, Murphy DG, Ost P, Padhani AR, Fanti S., Positron Emission Tomography and Whole-body Magnetic Resonance Imaging for Metastasis-directed Therapy in Hormone-sensitive Oligometastatic Prostate Cancer After Primary Radical Treatment: A Systematic Review., «EUROPEAN UROLOGY ONCOLOGY», 2021, 4, pp. 714 - 730 [articolo]
Morigi JJ, Anderson J, DE Nunzio C, Fanti S., Prostate specific membrane antigen positron emission tomography/computed tomography and staging high risk prostate cancer: a non-systematic review of high clinical impact literature., «MINERVA UROLOGY AND NEPHROLOGY», 2021, 73, pp. 32 - 41 [articolo]
Silvia Malavasi, Diletta Calabrò, Alessandro Bevilacqua, Claudio Ricci, Riccardo Casadei, Davide Campana, Stefano Fanti, Valentina Ambrosini, Radiomic analysis could allow detecting misassigned bioptic grading when discriminating G1 and G2 primary pancreatic neuroendocrine tumours imaged with 68Ga-DOTANOC PET/CT, in: ECR 2021 – BOOK OF ABSTRACTS, «INSIGHTS INTO IMAGING», 2021, pp. 1 - 1 (atti di: The 33rd European Congress of Radiology (ECR 2021), Vienna (Austria), March 3-7, 2021) [atti di convegno-abstract]
A. Bevilacqua, D. Calabrò, S. Malavasi, C. Ricci, R. Casadei, D. Campana, S. Fanti, V. Ambrosini;, Radiomic analysis performed on 68Ga-DOTANOC PET/CT allows discriminating primary pancreatic neuroendocrine tumour grading, in: ECR 2021 – BOOK OF ABSTRACTS, 2021, pp. 303 - 303 (atti di: The 33rd European Congress of Radiology (ECR 2021), Vienna (Austria), March 3-7, 2021) [Contributo in Atti di convegno]Open Access
Argalia, G; Fortunati, E; Calabrò, D; Malavasi, S; Campana, D; Casadei, R; Ricci, C; Bevilacqua, A; Fanti, S; Ambrosini, V, Radiomic Model Discriminating Low Grade Pancreatic Neuroendocrine Tumours Assessed by Biopsy of the Primary Lesion, «EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING», 2021, 48, pp. S525 - S526 [abstract]
Casadei B, Argnani L, Guadagnuolo S, Pellegrini C, Stefoni V, Broccoli A, Nanni L, Morigi A, Lolli G, Guarino M, Spinardi L, Pierucci E, Fanti S, Bartoletti M, Dicataldo M, Sabattini E, Bonifazi F, Zinzani PL., Real World Evidence of CAR T-Cell Therapies for the Treatment of Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma: A Monocentric Experience., «CANCERS», 2021, 13, pp. 4789 - 4789 [articolo]Open Access
Lalumera E.; Fanti S.; Boniolo G., Reliability of molecular imaging diagnostics, «SYNTHESE», 2021, 198, pp. 5701 - 5717 [articolo]Open Access
Zaorsky NG, Calais J, Fanti S, Tilki D, Dorff T, Spratt DE, Kishan AU., Recensione a: Salvage therapy for prostate cancer after radical prostatectomy., «NATURE REVIEWS. UROLOGY», 2021, 18, pp. 643 - 668 [recensione]
Zanoni L.; Fraccascia N.; Tabacchi E.; Bonfiglioli R.; Stanghellini V.; Barbara G.; Fanti S., SeHCAT test for bile acid malabsorption: may “the old” become “the gold one” in the diagnostic burden of chronic diarrhea?, «CLINICAL AND TRANSLATIONAL IMAGING», 2021, 9, pp. 177 - 180 [articolo]
Caffo O, Frantellizzi V, Monari F, Galli L, Costa RP, Pinto C, Tucci M, Baldari S, Facchini G, Bortolus R, Alongi F, Alongi P, Donner D, Fanti S, Sbrana A, Morabito A, Masini C, Zichi C, Pignata S, Borsatti E, Salgarello M, Spada M, De Giorgi U, Lo Re G, Cortesi E, De Vincentis G., Sequencing Life-Prolonging Agents in Castration-Resistant Prostate Cancer Patients: Comparison of Sequences With and Without 223Ra., «CANCER BIOTHERAPY & RADIOPHARMACEUTICALS», 2021, 36, pp. 391 - 396 [articolo]
Caffo O, Frantellizzi V, Monari F, Sbrana A, Costa RP, Pinto C, Tucci M, Baldari S, Facchini G, Bortolus R, Alongi F, Alongi P, Palermo A, Fanti S, Biasco E, Murabito A, Filice A, Zichi C, Pignata S, Borsatti E, Salgarello M, Spada M, Cortesi E, Vincentis G., Sequencing radium 223 and other life-prolonging agents in castration-resistant prostate cancer patients., «FUTURE ONCOLOGY», 2021, 17, pp. 807 - 815 [articolo]
Zamagni E.; Nanni C.; Dozza L.; Carlier T.; Bailly C.; Tacchetti P.; Versari A.; Chauvie S.; Gallamini A.; Gamberi B.; Caillot D.; Patriarca F.; Macro M.; Boccadoro M.; Garderet L.; Barbato S.; Fanti S.; Perrot A.; Gay F.; Sonneveld P.; Karlin L.; Cavo M.; Bodet-Milin C.; Moreau P.; Kraeber-Bodere F., Standardization of 18F-FDG-PET/CT According to Deauville Criteria for Metabolic Complete Response Definition in Newly Diagnosed Multiple Myeloma, «JOURNAL OF CLINICAL ONCOLOGY», 2021, 39, pp. 116 - 125 [articolo]
Serenari M.; Bonatti C.; Zanoni L.; Peta G.; Tabacchi E.; Cucchetti A.; Ravaioli M.; Pettinato C.; Bagni A.; Siniscalchi A.; D'Errico A.; Golfieri R.; Fanti S.; Cescon M., The role of hepatobiliary scintigraphy combined with spect/ct in predicting severity of liver failure before major hepatectomy: a single-center pilot study, «UPDATES IN SURGERY», 2021, 73, pp. 197 - 208 [articolo]Open Access
Abrams-Pompe RS, Fanti S, Schoots IG, Moore CM, Turkbey B, Vickers AJ, Walz J, Steuber T, Eastham JA., The Role of Magnetic Resonance Imaging and Positron Emission Tomography/Computed Tomography in the Primary Staging of Newly Diagnosed Prostate Cancer: A Systematic Review of the Literature., «EUROPEAN UROLOGY ONCOLOGY», 2021, 4, pp. 370 - 395 [articolo]
Zanoni L, Mei R, Bianchi L, Giunchi F, Maltoni L, Pultrone CV, Nanni C, Bossert I, Matti A, Schiavina R, Fiorentino M, Fonti C, Lodi F, D'Errico A, Brunocilla E, Fanti S., The Role of [18F]Fluciclovine PET/CT in the Characterization of High-Risk Primary Prostate Cancer: Comparison with [11C]Choline PET/CT and Histopathological Analysis., «CANCERS», 2021, 13, Article number: 1575, pp. 1 - 24 [articolo]Open Access
